Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Assembly Biosciences Q1 EPS $(1.17) Beats $(1.60) Estimate, Sales $9.42M Beat $7.63M Estimate

Author: Benzinga Newsdesk | May 08, 2025 03:52pm
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(1.17) per share which beat the analyst consensus estimate of $(1.60) by 26.88 percent. This is a 29.52 percent increase over losses of $(1.66) per share from the same period last year. The company reported quarterly sales of $9.42 million which beat the analyst consensus estimate of $7.63 million by 23.48 percent. This is a 62.82 percent increase over sales of $5.79 million the same period last year.

Posted In: ASMB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist